Home / Share Price Target / Blissgvs
Bliss GVS Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Bliss GVS Pharma Limited | |||
 | Symbol: BLISSGVS | ||
| Price: ₹129.06 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Bliss GVS Pharma Brief Company Overview
- 1.1: Bliss GVS Pharma Limited: A Trusted Healthcare Provider
- 1.1.1: Key Highlights:
- 1.2: Bliss GVS Pharma Financial Performance
- 1.2.1: Is Bliss GVS Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Bliss GVS Pharma Share Price Target For 2024
- 2.1.1: Bliss GVS Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Bliss GVS Pharma Share Price Prediction For 2024
- 2.2: Bliss GVS Pharma Share Price Target For 2025
- 2.2.1: Bliss GVS Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Bliss GVS Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Bliss GVS Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Bliss GVS Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Bliss GVS Pharma Past Performance
Bliss GVS Pharma Brief Company Overview
Bliss GVS Pharma Limited: A Trusted Healthcare Provider
Key Highlights:
- Renowned reputation in the pharmaceutical industry
- Diverse product range catering to multiple therapeutic areas
- Strong commitment to providing affordable and accessible healthcare
Established in 1984, Bliss GVS Pharma Limited has grown into a leading pharmaceutical company in India. With a vast product portfolio that includes pharma formulations, healthcare products, and therapeutic goods, the company offers a comprehensive range of soluciones de salud.
Bliss GVS Pharma Limited is dedicated to improving the lives of patients by providing high-quality medicines at affordable prices. The company's commitment to innovation and excellence has earned it a reputation for reliability and trust among healthcare professionals and patients alike.
Bliss GVS Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,332.6 Crore | Market valuation of Bliss GVS Pharma's shares. |
| Revenue (TTM) | 800.16 Crore | Total revenue generated by Bliss GVS Pharma over the past twelve months. |
| Net Income (TTM) | +63.42 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 15.84% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 7.92% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +2.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -42.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 8.98 | Company's total debt divided by total shareholder equity. |
| Total Debt | 94.17 Crore | Sum of Bliss GVS Pharma's current & long-term financial obligations. |
| Total Cash | 219.83 Crore | Total amount of liquid funds available to Bliss GVS Pharma. |
| Beta | 0.9 | Beta is less than 1 indicating that the Bliss GVS Pharma's price is less volatile than the market. |
Is Bliss GVS Pharma A Good Buy For Long Term?
Bliss GVS Pharma, a small-cap stock with a market capitalization of ₹1,242.77 crore, presents a mixed picture for long-term investment. While its ₹219.83 crore cash balance in Q2 2024-25 is positive, a significant debt of ₹94.17 crore and a substantial drop in earnings (-42.7% YoY) raise concerns. The low profit margin of 7.92% and negative returns over the past three, six, and YTD periods also suggest caution. Although past 12-month returns were positive (40.33%), considering the overall trend, it's not a good buy for the long term.
To predict the Bliss GVS Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Bliss GVS Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Bliss GVS Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bliss GVS Pharma shares in 2024, see the table below.
Bliss GVS Pharma Share Price Target Table For 2024
| Bliss GVS Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 134.35 (+4.09%) | Price Action: Nov 2019 Low |
| 2024 Target 2 | 132.89 (+2.96%) | Price Action: 22 Oct 2024 High |
| 2024 Target 1 | 130.85 (+1.38%) | Price Action: Apr 2024 High |
| Current Price | 129.06 | Bliss GVS Pharma's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 128.00 (-0.83%) | Price Action: Feb 2015 High |
| Stop Loss 2 | 126.61 (-1.9%) | Price Action: 18 Oct 2024 Low |
| Stop Loss 3 | 125.20 (-3%) | Price Action: 16 Oct 2024 Low |
Summary: Bliss GVS Pharma Share Price Prediction For 2024
In summary, Bliss GVS Pharma has surged by ₹4.41, achieving a notable +3.54% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Bliss GVS Pharma for 2024 predicts an additional rise of 1.38% to 4.09% by the end of 2024 with three potential targets T1: 130.85, T2: 132.89, T3: 134.35. Stop Loss at SL1: 128.00, SL2: 126.61, SL3: 125.20.
Bliss GVS Pharma has a 52-week high of ₹149.60, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹92.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Bliss GVS Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bliss GVS Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Bliss GVS Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bliss GVS Pharma shares in 2025, see the table below.
Bliss GVS Pharma Share Price Target Table For 2025
| Bliss GVS Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 176.66 (+36.88%) | Price Action: Chart |
| 2025 Target 2 | 173.37 (+34.33%) | Price Action: Chart |
| 2025 Target 1 | 171.65 (+33%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 129.06 | Bliss GVS Pharma's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 119.00 (-7.8%) | Price Action: 14 Nov 2024 High |
| Stop Loss 2 | 117.70 (-8.81%) | Price Action: Sep 2019 High |
| Stop Loss 3 | 116.45 (-9.78%) | Price Action: Jun 2021 High |
Summary: Bliss GVS Pharma Share Price Prediction For 2025
In summary, Bliss GVS Pharma has surged by ₹4.41, achieving a notable +3.54% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Bliss GVS Pharma for 2025 predicts an additional rise of 33% to 36.88% by the end of 2025 with three potential targets T1: 171.65, T2: 173.37, T3: 176.66. Stop Loss at SL1: 119.00, SL2: 117.70, SL3: 116.45.
Bliss GVS Pharma has a All-Time high of ₹221.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹92.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Bliss GVS Pharma, we have created a specific page for that check here: Bliss GVS Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Bliss GVS Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Bliss GVS Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 8.25% over the next 15 years.
For complete year by year Bliss GVS Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Bliss GVS Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Bliss GVS Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹129.06 | [Current Price] |
| 2024 | ₹121.03 | -6.23% |
| 2025 | ₹148.41 | 22.63% |
| 2026 | ₹173.1 | 16.62% |
| 2027 | ₹203.94 | 17.81% |
| 2028 | ₹202.5 | -0.71% |
| 2029 | ₹210.2 | 3.8% |
| 2030 | ₹243.72 | 15.94% |
| 2031 | ₹271.6 | 11.43% |
| 2032 | ₹308.14 | 13.45% |
| 2033 | ₹296.36 | -3.83% |
| 2034 | ₹299.37 | 1.01% |
| 2035 | ₹339.03 | 13.24% |
| 2036 | ₹370.11 | 9.16% |
| 2037 | ₹412.34 | 11.41% |
| 2038 | ₹390.23 | -5.37% |
| 2039 | ₹367.31 | -5.88% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bliss GVS Pharma Past Performance
- In 1993, Bliss GVS Pharma opening price was ₹0.27
- As of Thu 21 Nov 2024 the price stands at ₹129.06.
- This represents a Compound Annual Growth Rate (CAGR) of 21.26%.
- In 31 years, an investment of 10,000 would have become ₹47.8 Lakh.
As we wrap up, we hope you like our study on Bliss GVS Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Bliss GVS Pharma Share Price History
- Bliss GVS Pharma Price Target Tomorrow
- Bliss GVS Pharma Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
